OOIR: Observatory of International Research

Papers

(The H4-Index of Medicinal Research Reviews is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
	244
	216
In Memoriam: Professor Minyong Li (1976–2025)	197
Decoding Gene Expression Changes in Cerebral Tumors: Before and After Radiotherapy	174
Key characters of glycodrugs	153
Design, synthesis, and applications of ring‐functionalized histidines in peptide‐based medicinal chemistry and drug discovery	123
New drug approvals for 2022: Synthesis and clinical applications	118
Accelerating Small Molecule Ferroptosis Regulator Development With Advances in Biological Functions	113
Nanotechnology‐based electrochemical biosensors for monitoring breast cancer biomarkers	96
Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment	96
Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns	92
Galectin‐8 inhibition and functions in immune response and tumor biology	91
The role and prospect of lysine‐specific demethylases in cancer chemoresistance	90
Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria	85
Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders	84
	83
Front Cover Image, Volume 45, Issue 1	83
Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel	77
Current and emerging approaches to noncompetitive AR inhibition	77
Targeting Histone H3K9 Methyltransferase G9a as a Potential Therapeutic Strategy for Neuropsychiatric Disorders	65
Issue Information	65
Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer	65
Metal complexes bearing EGFR‐inhibiting ligands as promising anticancer agents	50
A Focus on Natural Autophagy Modulators as Potential Host‐Directed Weapons Against Emerging and Re‐Emerging Viruses	47
Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases	44

Mechanism and application of β‐adrenoceptor blockers in soft tissue wound healing	43
The ethnomedicinal and functional uses, phytochemical and pharmacology of compounds from Ardisia species: An updated review	43
Smart Integration of Structural Biology and Medicinal Chemistry to Unlock Target‐Driven Drug Discovery	43
An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators	40
Mitochondrial quality control proteases and their modulation for cancer therapy	40
Current nanocomposite advances for biomedical and environmental application diversity	40
α‐Synuclein in Parkinson's Disease: From Bench to Bedside	40
Emerging roles of nerve‐bone axis in modulating skeletal system	39
A Possibility of Synthetic Lethality: Wee1 Kinase as a Promising Treating Target for Cancer	37
Targeting lysosomal quality control as a therapeutic strategy against aging and diseases	37
Enhancing healthy aging with small molecules: A mitochondrial perspective	37
Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis	36
Issue Information	36